Search

everythinglearnresearchcommunity

for

Search:↓

Auto-antibody testing is a useful but not definitive tool in diagnosing interstitial lung diseases, and using a specific algorithm could make testing more cost-effective.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

GLP-1 receptor agonists can help skin conditions but may cause hair loss and other skin issues.

Some patients receiving pegylated interferon alfa injections developed skin necrosis, requiring treatment adjustments or discontinuation.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Calcipotriene ointment improved a child's skin condition known as En coup de sabre.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

Ixekizumab effectively treated severe psoriasis and hair loss in a patient.

Combining pentoxifylline with corticosteroids improves alopecia areata treatment.

Mycophenolate mofetil is safer and more effective than cyclophosphamide for treating lupus nephritis.

Infliximab was effective in treating a scalp condition that did not respond to other treatments.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

A patient with a new PLEC gene mutation showed symptoms of both muscular dystrophy and myasthenia gravis, which improved with steroid treatment.

All four treatments for early rheumatoid arthritis had similar safety profiles.

Certain medications can cause serious side effects, so it's important to report them.

PEGylated liposomal doxorubicin improves cancer treatment effectiveness and reduces side effects like heart damage and hair loss.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

Selective immunotherapies like anifrolumab and belimumab are more effective for treating systemic lupus erythematosus than traditional drugs.

Clofazimine effectively treated ashy dermatosis in a patient.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

A woman with inflammatory bowel disease improved after treatment with ustekinumab for a rare skin condition associated with her disease.

Mogamulizumab, a skin cancer drug, may cause hair loss similar to alopecia areata.

Troglitazone increases subcutaneous fat in lipodystrophy patients.

A patient's grey hair regained color during treatment with adalimumab.

A man was diagnosed with a rare form of lupus after showing unique skin symptoms that responded well to treatment.